US Critical Metals Corp
USCM
Three Valley Copper Corp
TVC.H
Windfall Geotek Inc
WIN
Revive Therapeutics Ltd
RVV
Global Hemp Group Inc
GHG
CA Stock MarketDetailed Quotes
BMND Biomind Labs Inc
- 0.390
- -0.190-32.76%
15min DelayTrading Dec 3 09:47 ET
30.24MMarket Cap-21666P/E (TTM)
0.390High0.360Low1.50KVolume0.360Open0.580Pre Close570.00Turnover1.09052wk High0.00%Turnover Ratio77.53MShares0.02552wk Low-0.018EPS TTM30.24MFloat Cap61.750Historical HighLossP/E (Static)77.53MShs Float0.025Historical Low-0.027EPS LYR5.17%Amplitude--Dividend TTM-13.93P/B1Lot Size--Div YieldTTM
Biomind Labs Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -29.37%90.85K | -69.81%108.54K | -73.07%110.67K | -66.22%991.43K | -82.41%92.39K | -85.73%128.64K | -53.92%359.48K | -43.24%410.93K | -14.38%2.93M | -55.55%525.19K |
| Selling and administrative expenses | 224.67%53.79K | -49.99%58.31K | -83.80%44.84K | -80.49%407.8K | -197.13%-217.96K | -97.81%16.57K | -79.05%116.61K | -48.81%276.82K | -21.35%2.09M | -77.07%224.4K |
| -General and administrative expense | 224.67%53.79K | -49.99%58.31K | -83.80%44.84K | -80.49%407.8K | -197.13%-217.96K | -97.81%16.57K | -79.05%116.61K | -48.81%276.82K | -21.35%2.09M | -77.07%224.4K |
| Research and development costs | -133.04%-12.3K | --0 | --0 | -46.57%306.95K | -80.43%48.82K | -50.96%37.23K | 0.94%158.61K | -38.33%62.29K | 0.61%574.44K | 179.95%249.41K |
| Depreciation amortization depletion | 0.00%2.23K | 0.00%2.23K | -53.23%2.23K | -65.76%15.15K | -100.01%-1 | -79.56%2.23K | -81.19%2.23K | -46.31%4.77K | 56.22%44.24K | 14.19%10.37K |
| -Depreciation and amortization | 0.00%2.23K | 0.00%2.23K | -53.23%2.23K | -65.76%15.15K | -100.01%-1 | -79.56%2.23K | -81.19%2.23K | -46.31%4.77K | 56.22%44.24K | 14.19%10.37K |
| Other operating expenses | -35.09%47.13K | -41.48%48K | -5.13%63.61K | 15.78%261.53K | ---- | 27.59%72.6K | 50.00%82.03K | -8.51%67.05K | 32.36%225.88K | -60.82%41.01K |
| Operating profit | 29.37%-90.85K | 69.81%-108.54K | 73.07%-110.67K | 66.22%-991.43K | 82.41%-92.39K | 85.73%-128.64K | 53.92%-359.48K | 43.24%-410.93K | 14.38%-2.93M | 55.55%-525.19K |
| Net non-operating interest income (expenses) | -59.64K | -86.03K | -88,406.90%-77K | -11,757.97%-161.39K | -20,779.49%-161.3K | 0 | 0 | 89.19%-87 | 63.35%-1.36K | 163.21%780 |
| Non-operating interest expense | --59.64K | --86.03K | 88,406.90%77K | 11,757.97%161.39K | 20,779.49%161.3K | --0 | --0 | -89.19%87 | -63.35%1.36K | -163.21%-780 |
| Other net income (expenses) | 3,738.46%115.96K | -964.98%-17.49K | 106.70%1.52K | 19.62%-39.64K | -116.21%-18.37K | 113.69%3.02K | 95.57%-1.64K | 47.64%-22.65K | 94.53%-49.31K | -104.97%-8.5K |
| Gain on sale of security | -877.79%-23.5K | -964.98%-17.49K | 106.70%1.52K | 19.62%-39.64K | -116.21%-18.37K | 113.69%3.02K | 95.57%-1.64K | 47.64%-22.65K | 23.50%-49.31K | -122.64%-8.5K |
| Other non-operating income (expenses) | --139.46K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 72.51%-34.53K | 41.28%-212.06K | 57.07%-186.16K | 60.06%-1.19M | 48.95%-272.06K | 86.41%-125.62K | 55.86%-361.12K | 43.53%-433.66K | 31.09%-2.99M | 55.10%-532.91K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 72.51%-34.53K | 41.28%-212.06K | 57.07%-186.16K | 60.06%-1.19M | 48.95%-272.06K | 86.41%-125.62K | 55.86%-361.12K | 43.53%-433.66K | 31.09%-2.99M | 55.10%-532.91K |
| Net income continuous operations | 72.51%-34.53K | 41.28%-212.06K | 57.07%-186.16K | 60.06%-1.19M | 48.95%-272.06K | 86.41%-125.62K | 55.86%-361.12K | 43.53%-433.66K | 31.09%-2.99M | 55.10%-532.91K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 72.51%-34.53K | 41.28%-212.06K | 57.07%-186.16K | 60.06%-1.19M | 48.95%-272.06K | 86.41%-125.62K | 55.86%-361.12K | 43.53%-433.66K | 31.09%-2.99M | 55.10%-532.91K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 72.51%-34.53K | 41.28%-212.06K | 57.07%-186.16K | 60.06%-1.19M | 48.95%-272.06K | 86.41%-125.62K | 55.86%-361.12K | 43.53%-433.66K | 31.09%-2.99M | 55.10%-532.91K |
| Diluted earnings per share | 77.70%-0.0004 | 40.00%-0.003 | 50.00%-0.003 | 50.00%-0.02 | 60.00%-0.008 | 83.33%-0.002 | 54.55%-0.005 | 40.00%-0.006 | 33.33%-0.04 | -11.11%-0.02 |
| Basic earnings per share | 77.70%-0.0004 | 40.00%-0.003 | 50.00%-0.003 | 50.00%-0.02 | 60.00%-0.008 | 83.33%-0.002 | 54.55%-0.005 | 40.00%-0.006 | 33.33%-0.04 | -11.11%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.